Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Mitsiades

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Essays in Biochemistry|October 28, 2005
Proteasome inhibitors as therapeuticsConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Current Drug Targets|November 1, 2006
Proteasome inhibition as a new therapeutic principle in hematological malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Expert Review of Anticancer Therapy|July 9, 2005
Proteasome inhibition as a therapeutic strategy for hematologic malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Cancer Letters|February 5, 2022
Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomicsDallin Lowder, Kinza Rizwan, Collin McColl, et al.
The American Journal of Pathology|December 6, 2002
Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viabilityVassiliki Poulaki, Constantine S Mitsiades, Antonia M Joussen, et al.
Seminars in Oncology|April 30, 2003
Novel biologically based therapies for Waldenstrom's macroglobulinemiaConstantine S Mitsiades, Nicholas Mitsiades, Paul G Richardson, et al.
Journal of the American Academy of Dermatology|April 17, 2007
Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like diseaseAkhil Wadhera, Emanual Maverakis, Nicholas Mitsiades, et al.
Investigative Ophthalmology & Visual Science|June 26, 2009
Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathyEirini Iliaki, Vassiliki Poulaki, Nicholas Mitsiades, et al.
Investigative Ophthalmology & Visual Science|August 11, 2011
Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapyNicholas Mitsiades, Sue Anne Chew, Bin He, et al.
The American Journal of Pathology|July 28, 2004
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathyVassiliki Poulaki, Antonia M Joussen, Nicholas Mitsiades, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Essays in Biochemistry|October 28, 2005
Proteasome inhibitors as therapeuticsConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Current Drug Targets|November 1, 2006
Proteasome inhibition as a new therapeutic principle in hematological malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Expert Review of Anticancer Therapy|July 9, 2005
Proteasome inhibition as a therapeutic strategy for hematologic malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Cancer Letters|February 5, 2022
Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomicsDallin Lowder, Kinza Rizwan, Collin McColl, et al.
The American Journal of Pathology|December 6, 2002
Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viabilityVassiliki Poulaki, Constantine S Mitsiades, Antonia M Joussen, et al.
Seminars in Oncology|April 30, 2003
Novel biologically based therapies for Waldenstrom's macroglobulinemiaConstantine S Mitsiades, Nicholas Mitsiades, Paul G Richardson, et al.
Journal of the American Academy of Dermatology|April 17, 2007
Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like diseaseAkhil Wadhera, Emanual Maverakis, Nicholas Mitsiades, et al.
Investigative Ophthalmology & Visual Science|June 26, 2009
Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathyEirini Iliaki, Vassiliki Poulaki, Nicholas Mitsiades, et al.
Investigative Ophthalmology & Visual Science|August 11, 2011
Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapyNicholas Mitsiades, Sue Anne Chew, Bin He, et al.
The American Journal of Pathology|July 28, 2004
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathyVassiliki Poulaki, Antonia M Joussen, Nicholas Mitsiades, et al.
Pageof 13